what insurance covers glp 1 for weight loss glp-1 drugs Ole Miss researchers study barriers to coverage GLP-1 Weight-Loss Drug Demonstration Begins – Lost insurance coverage for GLP-1

The disconnect between the population prevalence of obesity and care utilization is driven by a range of factors such as stigma and discrimination in healthcare settings, lack of educational and cultural training among physicians on how to address this issue with patients, and the cost of treatment

This is even more relevant if you happen to have special requirements due to an underlying medical condition

Roy, A., Sikdar, J., Seal, P., & Haldar, R

We need studies on humans to establish its safety and efficacy

Shah AD, Langenberg C, Rapsomaniki E, et al

Metabolic research models update: cardiovascular risk and investigational innovations [PMID: 40248309] Laboratory literature summary: metabolic research models update: cardiovascular risk and investigational innovations (focus on semaglutide and tirzepatide)